Health ❯Healthcare

Obesity

Treatment Options Weight Loss Weight Management Weight Loss Treatments Health Risks Obesity Management Treatment Methods Childhood Obesity Obesity Treatments Weight Loss Drugs

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

High BMI and Black Patients Face Greater Minor Complication Risks After Bariatric Surgery

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections

Waist-to-Height Ratio Found to Strongly Predict Heart Failure Risk

Brain Neurons Found to Drive Type 2 Diabetes, Independent of Obesity

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

UK Government Proposes Pharmacy Access for Weight-Loss Jabs Amid Rising Demand

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances